28-29 October 2025
RAI Congress Centre, Amsterdam
Join us at the World Orphan Drug Congress Europe Conference this October.
The World Orphan Drug Congress is the largest and most established orphan drug & rare disease meeting of its kind across the globe.
From cell and gene therapy, genetic testing, and market access, to real world evidence, this one meeting covers the whole orphan drugs value chain where science, government and manufacturers all come together to create groundbreaking progress.
Sven Tops, Chief Market Access Officer and Dr. Lydia Frick, Director of Market Access will be presenting on the following topic: “How can AI drive the success of the orphan drug journey from early development through pricing & reimbursement?”
We look forward to seeing you there for an insightful discussion.
